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Abstract
Background: Lung cancer was the second highest absolute cancer incidence globally and the first cause of
cancer mortality in 2014. Indoor radon is the second leading risk factor of lung cancer after cigarette smoking
among ever smokers and the first among non-smokers. Environmental burden of disease (EBD) attributable to
residential radon among non-smokers is critical for identifying threats to population health and planning
health policy.
Methods: To identify and retrieve literatures describing environmental burden of lung cancer attributable to
residential radon, we searched databases including Ovid-MEDLINE, -EMBASE from 1980 to 2016. Search
terms included patient keywords using ‘lung’ , ‘neoplasm’ , exposure keywords using ‘residential’ , ‘radon’ ,
and outcomes keywords using ‘years of life lost’ , ‘years of life lost due to disability’ , ‘burden’. Searching
through literatures identified 261 documents; further 9 documents were identified using manual searching.
Two researchers independently assessed 271 abstracts eligible for inclusion at the abstract level. Full text
reviews were conducted for selected publications after the first assessment. Ten studies were included in
the final evaluation.
Review: Global disability‐adjusted life years (DALYs)(95 % uncertainty interval) for lung cancer were
increased by 35.9 % from 23,850,000(18,835,000-29,845,000) in 1900 to 32,405,000(24,400,000-38,334,000) in
2000. DALYs attributable to residential radon were 2,114,000(273,000-4,660,000) DALYs in 2010. Lung cancer
caused 34,732,900(33,042,600 ~ 36,328,100) DALYs in 2013. DALYs attributable to residential radon were
1,979,000(1,331,000-2,768,000) DALYs for in 2013. The number of attributable lung cancer cases was 70-900
and EBD for radon was 1,000-14,000 DALYs in Netherland. The years of life lost were 0.066 years among
never-smokers and 0.198 years among ever-smoker population in Canada.
Conclusion: In summary, estimated global EBD attributable to residential radon was 1,979,000 DALYs for both
sexes in 2013. In Netherlands, EBD for radon was 1,000–14,000 DALYs. Smoking population lost three times
more years than never-smokers in Canada. There was no study estimating EBD of residential radon among
never smokers in Korea and Asian country. In addition, there were a few studies reflecting the age of
building, though residential radon exposure level depends on the age of building. Further EBD study
reflecting Korean disability weight and the age of building is required to estimate EBD precisely.
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Background
There were an estimated 1.8 million incident cases of
tracheal, bronchus, and lung cancer (TBL cancer) and
1.6 million deaths in 2013. TBL cancer was the first
cause of cancer mortality as well as the second highest
absolute incidence globally in 2014 [1]. Furthermore
age-standardized rates were the first in both incidence
and death. In Korea, it is the third cause of cancer inci-
dence with 15,376 cases in males and the fifth cancer
with 6,751 cases in females in 2012 [2]. In Korea, the
most frequent neoplasm mortality is TBL cancer in both
sexes in 2014 [3].
International agency for research on cancer (IARC)
classified many risk factors as the carcinogenic agents
with sufficient evidence in humans including tobacco
smoking, radon-222 and its decay, and second hand
smoke. In the outdoor air, radon gas from the soil is
diluted to low concentrations with a negligible threat
to health [4]. However, indoor radon can accumulate
to high levels when it confined to enclosed spaces
with poor ventilation. Residential radon is the second
leading risk factor of lung cancer after cigarette
smoking among ever smokers and the first among
non-smokers (Additional file 1: Table S1) [4].
Recently, a systematic review on the carcinogenicity
of the residential radon in never smokers concluded
that there seems to be an association based on few of
the included studies which mostly did not focus on
the association among never smokers [5].
Understanding the disease burden among major health
problems and the transition pattern of the burden over
time is also critical for planning global and national
health policy. If a public policy addresses the major
causes of disease burden, the policy could effectively
contribute to the health of populations. For example,
mass prevention will be possible even tiny reductions of
population exposure which affect incident rate of
emerging burden [6].
In addition, the principal advantage of comprehensive
quantification of disease burden attributable to risk
factors, particularly of modifiable factors, is critical for
identifying large threats to population health and that it
provides the evidence base for prevention strategies. The
Global Burden of Disease (GBD) study organized risk
factors into three categories; behavioral, environmental
and occupational, and metabolic risks. Environmental
burden of disease (EBD) is a disability‐adjusted life year
(DALY) attributable to the environmental risk factors
exposure. EBD is also a tool to monitor the priority of
environmental risks and to make policies for the
environmental health, and to evaluate the outcome of
these policies afterwards.
The objective of the present study is a review of the
theme of EBD of residential radon among non-smokers.
Methods
Search strategy
To identify and retrieve all relevant literature describing
environmental burden of lung cancer attributable to
residential radon, we searched databases including Ovid-
MEDLINE (1948 to 5 January, 2016), Ovid-EMBASE
(1980 to 5 January, 2016). Language restrictions did not
apply to any of the searches. Search terms included
patient keywords using ‘cancer’, ‘neoplasm’, exposure
keywords using ‘residential’, ‘radon’, and outcomes key-
words using ‘years of life lost’, ‘years of life lost due to
disability’, ‘years lived with disability’, ‘burden’, ‘cost’. All
261 abstracts were reviewed using a combination of the
search terms. Literature searches are summarized in
Additional file 1: Table S1. We completed searches on
January 5, 2016.
Study selection
Two researchers independently assessed publications
considered to be eligible for inclusion at the title and/or
abstract level. Full text reviews were conducted for the
selected publications after the first assessment. Studies
were included: 1) suspected lung cancer patients; 2)
appropriate outcomes were reported. We excluded: 1)
non-human, pre-clinical studies; 2) studies that are not
written in English or Korean; 3) studies that are not
original articles, gray literature, case reports. Searching
through the literature identified 261 documents; 9
documents were identified using manual searching.
Among these, 179 documents met our exclusion criteria.
81duplicated data from other reports were also excluded.
A total of 10 studies were included in the final evaluation
(Fig. 1, Additional file 1: Table S3).
Review
Disease burden for the population could be estimated by
the objective method that captures both the severity of
illness and premature mortality. In 1990, GBD study
proposed DALYs as a summary metric of population
health [7, 8]. DALYs are a health gap between the
current state of a population’s health and the goal of
standard life expectancy in ideal health. No systematic
reassessment of disease-specific burden worldwide has
been done since the 1990 study. In the GBD 2010 results
on health loss related to specific diseases and risk factors
were reported: prevalence and prevalence rates for
sequelae, years lived with disability (YLDs), deaths and
death rates, years of life lost due to premature mortality
(YLLs), and DALYs for 21 regions and worldwide in
1990, 2005 and 2010.
YLDs were calculated as the prevalence of sequelae of
lung cancer by age, sex, and weighted by disability
weights for lung cancer. Prevalence estimation for
sequelae begins with a systematic review of all available
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data sources for incidence, remission, prevalence, and
excess mortality. A Bayesian meta-regression method
developed for the GBD 2010 (DisMod-MR) have been
used to make all age-sex-country-year-specific estimates.
The DisMod-MR is a generalized negative binomial
model with age-standardized fixed effects and country
level random effects [9]. The disability weights of GBD
1990 relied on judgments of health-care professionals;
however, those of GBD 2010 derived from judgments of
the general public about health severity.
YLLs were calculated from age-, sex-, country-, and
time-specific mortality estimates by lung cancer, with
death by standardized lost life expectancy at each age
with reference to a new reference-standard life expect-
ancy at each age. In the GBD 1990, DALYs were
computed using 3 % discount rate and age weights that
placed on the base case for emphasizing health out-
comes in young adults. However neither YLLs nor YLDs
were discounted or age-weighted in the GBD 2010.
DALYs for lung cancer, as the sum of YLDs and YLLs,
were calculated for sexes, 20 age groups, and 187 coun-
tries specific estimates, and aggregated estimates three
points in time. Standard simulation methods were used
to maintain the consistency between the sum of
cause-specific mortality and independently assessed
levels of all-cause mortality derived from demographic
sources [9, 10]. Uncertainty around DALYs was incor-
porated in levels of all-cause mortality, cause-specific
mortality, prevalence, and disability weights in each
age-sex-country-year. Standard simulation methods by
taking 1000 draws from the uncertainty distribution
of RR, prevalence of residential radon exposures, TMRED,
and lung cancer estimates, disability weights for each
age, sex, country, year simulation analysis was used to
capture uncertainty in lung cancer prevalence and
death model predictions. Of the 1000 draws, the 25th
and 975th value were reported as the 95 % uncertainty
intervals (95 % UI).
Global DALYs due to all cause remained stable from
1990 (2,502,601,000) to 2010 (2,490,385,000). DALYs
(95 % Uncertainty Interval) for lung cancer were increased
by 35.9 % from 23,850,000 (18,835,000–29,845,000)
DALYs in 1900 to 32,405,000 DALYs (24,400,000–
38,334,000) in 2000. Crude DALYs were decreased by
23 % (4,720,500,000 to 3,614,500,000). Those for lung
cancer increased by 4.5 % from 45,000,000 (35,500,000–
56,300,000) to 47,000,000 (35,400,000–55,600,000) [11].
According to the order based on the mean DALYs,
lung cancer increased from 24th to 22nd rank. There
was heterogeneity in rankings of lung cancer burden
among regions (Additional file 1: Table S4). DALYs
for Lung cancer had high rates in the high-income
regions [11].
The GBD 2010 was the first study to quantify uncer-
tainty as the strength of the evidence on the burden of
lung cancer. In addition, a systematic analysis of the
proportion of disease burden caused by 67 specific risk
factors including residential radon was undertaken to
assess changes over time from 1990 to 2010 [12].
Disease burden of lung cancer attributable to residential
radon was estimated following five steps: 1) selection of
outcomes based on criteria about causal associations 2)
modeling approach to estimate exposure distributions
for each countries, sex, and age group; 3) estimation of
relative risk per unit exposure for residential radon; 4)
the choice of optimum exposure distribution, which was
termed theoretical-minimum-risk exposure distribution
(TMRED); 5) computation of burden attributable to resi-
dential radon by comparing the present distribution of
exposure to the TMRED for each sex, and age group
with 95 % UI.
Selected outcomes were trachea, bronchus, and lung
cancers. The main data source for exposure was direct
household measurements from surveys. The modeling
approach used for estimation of current residential
radon exposure distributions was mixed effect regres-
sion. The prediction of exposure distributions was done
with testing many covariates, which were collected in
the database at the Institute for Health Metrics and
Evaluation for GBD 2010. The source of effect size
per unit exposure was the publication of Darby and
colleagues [13]. TMRED of residential radon was
10 Bq/m3. By comparing the present distribution of
Fig. 1 Documents selected for evaluation of the assessment according
to the literature search strategy
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exposure to the TMRED for each age group, sex in
2010, the burden attributable to continuous residen-
tial radon exposure was calculated according to the
following formula.
PAF ¼
Z m
x¼0
RR xð Þ⋅P1 xð Þdx−
Z m
x¼0
RR xð Þ⋅P2 xð Þdx
Z m
x¼0
RR xð Þ⋅P1 xð Þdx
RR (x) is RR at exposure level x, P1(x) is the (mea-
sured or estimated) population distribution of radon
exposure, P2(x) is TMRED, which is the counterfactual
distribution of exposure, and m is the maximum
exposure level.
Estimated global deaths and DALYs attributable to
residential radon were 98,992 (95 % UI 13,133–
215,237) deaths and 2,114,000 (273,000–4,660,000)
DALYs, respectively, for both sexes in 2010 (Table 2).
The effect of residential radon exposure on population
health differed between sexes [12]. For instance, the
fraction of disease burden attributable to residential
radon for lung cancer was about 2.5 times higher for
men than for women in 2010 (1,514,000 DALYs for
men vs 600,000 for women). Further distribution of
lung cancer mortality and disease burden attributable
to residential radon reveals several patterns by age
group (Table 1). Globally, ranked by the attributable
burden, residential radon rankings were ranged from
the 27th to the 43th (Table 2) [12].
The strengths of the study by Lim SS et al [12].
included the incorporation of more data for residential
radon exposure, sophisticated methods to handle miss-
ing data, comparability of methods, use of TMRED as
the counterfactual distribution with which observed
exposures are compared, and global patterns with re-
gional variation in risks to lung cancer. Like other
disease burden studies, there were also some limitations.
First, in the estimates of effect sizes, residual confound-
ing cannot be definitively adjusted. Second, the external
validity of the effect size to diverse population still
remains questionable due to uncertainty. Third, the
effect size could change over time that effect size inte-
grated using evidences across different periods could not
reflect temporal change in residential radon. Fourth, the
assumption that all other factors were independent, in
the quantification of attributable burden of residential
radon, could be incorrect. Fifth, there were not any
Table 1 Global DALYs of lung cancer and deaths attributable to residential radon by age and sex in 2010 with 95 % UI
DALYs (in thousands) Deaths
Both sexes Male Female Both sexes Male Female
All Ages 2,114 (273–4,660) 1,514 (191–3,383) 600 (84–1,355) 98,992 (13,133–215,237) 70,014 (9,140–154,460) 28,978 (4,098–64,387)
0–6 Days 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
7–27 Days 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
28–364 Days 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
1–4 Years 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
5–9 Years 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
10–14 Years 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
15–19 Years 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
20–24 Years 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
25–29 Years 11 (1–27) 7 (1–18) 4 (0–10) 179 (19–460) 118 (12–311) 61 (6–174)
30–34 Years 20 (2–48) 12 (1–31) 7 (1–20) 361 (42–894) 227 (26–564) 134 (17–371)
35–39 Years 40 (5–100) 26 (3–62) 15 (2–37) 815 (97–2,018) 516 (58–1,250) 298 (36–756)
40–44 Years 88 (11–209) 57 (6–135) 31 (4–74) 1,979 (252–4,700) 1,284 (142–3,042) 696 (96–1,665)
45–49 Years 154 (20–352) 105 (13–243) 48 (7–112) 3,884 (506–8,889) 2,662 (324–6,136) 1,222 (168–2,836)
50–54 Years 247 (32–544) 177 (22–393) 70 (9–157) 7,079 (921–15,575) 5,081 (638–11,274) 1,998 (267–4,503)
55–59 Years 343 (44–785) 253 (31–580) 90 (14–205) 11,324 (1,463–25,961) 8,358 (1,026–19,168) 2,965 (446–6,775)
60–64 Years 348 (44–774) 258 (33–570) 90 (12–201) 13,548 (1,724–30,220) 10,053 (1,288–22,176) 3,494 (477–7,851)
65–69 Years 306 (39–667) 225 (29–503) 82 (12–181) 14,401 (1,845–31,358) 10,552 (1,339–23,633) 3,849 (553–8,534)
70–74 Years 271 (36–586) 196 (26–426) 74 (11–165) 15,897 (2,099–34,473) 11,536 (1,533–25,026) 4,362 (630–9,719)
75–79 Years 181 (25–398) 128 (17–282) 53 (8–123) 13,896 (1,932–30,443) 9,792 (1,312–21,581) 4,104 (597–9,477)
80+ Years 106 (15–223) 70 (10–148) 37 (5–81) 15,630 (2,235–32,630) 9,834 (1,413–20,831) 5,796 (841–12,628)
DALYs disability-adjusted life-years, UI uncertainty intervals
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DALYs attributable to residential radon for subpopula-
tion by the smoking status.
In 2015, GBD study 2013 reassessed the risk factors
with new data for exposure, relative risks, and evi-
dence on the counterfactual radon exposure distribution
[14, 15]. In general, the analysis used the comparative risk
assessment methods of the GBD 2010. The estimates of
attributable deaths, YLL, YLD, and DALYs of lung cancer
have been estimated for 79 risks or clusters of risks,
including residential radon. Conceptually, the amount of
lung cancer disease burden observed in a given year was
calculated and that attributable to past exposure to
residential radon was evaluated.
The attributable burden for radon in the specific
sex s, age group a, country c and year t (ABRn_asct)
was estimated as the sum, of DALYs for cause lung
cancer (DALYLC_asct) multiplied by PAF for lung
cancer due to indoor radon (PAFRn_LC_asct) following
the equation.
ABRnasct ¼
XW
DALYLCasct⋅PAFRnLCasct
¼
XW
ðYLLLCasct þ YLDLCasctÞ⋅PAFRnLCasct
The PAFRn_LC_asct was defined in each group was
defined as
PAFRnLCasct ¼
Z u
x¼l
RRRnLCasc xð Þ⋅PRnasct xð Þdx−RRRnLCasc TMRELRnasð ÞZ u
x¼l
RRRnLCasc xð Þ⋅PRnasct xð Þdx
RRRn_LC_asc (x) is a function of exposure level x for risk
factor residential radon, lung cancer, age-group a, sex s, and
country c. PRn_asct (x) is the radon exposure distribution
function for in age-group a, sex s, country c, and year t. l is
the lowest level and u is the highest level of exposure ob-
served. TMRELRn_as is the theoretical minimum radon
exposure level, which is the counterfactual level of risk ex-
posure that is minimum overall risk theoretically possible to
achieve, for age group a, and sex s and the single level of
radon exposure that minimize risk from all cause of DALYs.
The exposure of residential radon was defined as the
average daily exposure to indoor air radon levels
measured in Becquerel (radon disintegrations per s) per
cubic meter (Bq/m3) and the TMREL was 10 Bq/m3, the
outdoor concentration of radon. New country-level aver-
age data for radon exposure were added after the GBD
2010 and the modeling process was also updated. The
methodology to synthesize radon exposure data has been
moderately changed from a mixed effects regression
model to spatiotemporal Gaussian process regression
(ST-GPR). Only for risk factors with sufficient data in
standard age groups or at the household level, ST-GPR
has been used to estimate a flexible time trend. The RR
and TMREL were not updated for the GBD 2013.
At the global level, the correlation of the DALYs
attributable to the same risks for the year 2010 between
GBD 2010 and GBD 2013 was 0.97. Estimated global
deaths and DALYs attributable to residential radon were
92,000 (95 % UI 61,000–128,000) deaths and 1,979,000
(1,331,000–2,768,000) DALYs, respectively, for both sexes
in 2013.
Similar study for the burden in the United States
was published in 2013. US Burden of Disease Collab-
orators estimated burden of diseases, injuries, and risk
factors, which included environmental risk factors
[16]. Following the conceptual framework for risk fac-
tors developed for the GBD [17], authors estimated
the deaths or DALYs related to the environmental
causes including residential radon. The process of
computation was consists of 3 key steps. The first
step was inclusion of the risk-outcome pairs. Residen-
tial radon was “convincing” or “probable” for only
lung cancer according to the grading system defined
Table 2 Global deaths, DALYs for both sexes attributable to residential radon in 1990, 2010, and 2013 with 95 % UI
All risk factors Environmental risks Residential radon
1990 deaths (in thousands) 25,085 (24,385 to 25,821) 8,492 (8,036 to 8,953) 63 (41 to 86)
2010 deaths (in thousands) N/A N/A 99 (13–215)
2013 deaths (in thousands) 30,839 (29,719 to 31,949) 8,181 (7,651 to 8,726) 92 (61 to 128)
Median percent change deaths 23.0 % (19.0 to 27.3) −3.7 % (−9.6 to 2.4) 46.3 % (13.1 to 87.9)
Median percent change of age standardized deaths PAF 0.6 % (−1.0 to 2.0) −15.5 % (−19.8 to 11.1) 13.8 % (−11.7 to 44.3)
1990 DALYs (in thousands) 1,035,987 (980,813 to 1,092,478) 400,345 (374,489 to 424,432) 1,503 (984 to 2,086)
2010 DALYs (in thousands) 2,490,385 (95 % UI NA) N/A 2,114 (2,73–4660)
2013 DALYs (in thousands) 996,554 (927,157 to 1,072,340) 289,517 (265,778 to 312,094) 1,979 (1,331 to 2,768)
Median percent change DALYs −3.8 % (−7.7 to −0.1) −27.7 % (−32.1 to −23.2) 31.7 % (2.4 to 67.6)
Median percent change of age standardized DALYs PAF −3.8 % (−6.0 to −1.8) −22.6 % (−26.1 to −19.1) 7.1 % (−17.0 to − 36.9)
DALYs disability-adjusted life-years, PAF population attributable fraction, UI uncertainty intervals
The estimates in 1990 used the result of GBD 2013
Percent change is the change of estimates between 1990 and 2013
Noh et al. Annals of Occupational and Environmental Medicine  (2016) 28:12 Page 5 of 8
by the World Cancer Research Fund [18]. Based on
systematic reviews and meta-analyses of relative risks
for diseases due to specific risks and exposure re-
searches, deaths and DALYs were related to risk fac-
tors. Relative risk of lung cancer due to residential
radon exposure for both sexes aged 0-80 + years was
1.002 (1.00 - 1.003) per 1 Bq/m3. In the second step,
the age-, sex- specific distribution of residential radon
exposure was estimated from other published data sources
[12]. The third step was the estimation of deaths or
DALYs associated with residential radon by comparing the
current distribution of exposure with TMRED of exposure
selected for each risk factor. The age-standardized DALY
and all age DALY of lung cancer due to residential
radon was 183,200 (18,800 – 514,200) and 4,200,000
(430,000 – 11,720,000), respectively in 2010.
In 2013, the study of burden of disease related to
indoor air in Netherlands [19] reported that the second
largest most important indoor air pollutants were radon
and thoron from soils and building materials following
environmental tobacco smoke. Lung cancer as health
effect was selected because there was ‘sufficient evidence
of an association’ with the indoor radon according to
WHO and meta-analysis [20, 21]. All Dutch inhabitants
were considered as the population exposed to indoor
radon. The level of radon exposure was based on
measurements in newly built homes, which estimated
that the average indoor radiation dose due to radon is
0.39 mSv per year in the Netherlands. The exposure − ef-
fect relationship, in BEIR-VI [22], stratified by smoking
status was used to quantify the effects size of radon ex-
posure. PAF was calculated following equations.
AF ¼ RR−1ð Þ
RR
PAF ¼ AF⋅F
AB ¼ PAF⋅P
DALY ¼ AB⋅D⋅S
RR is a relative risk of 0.39 mSv radon exposure per
year. F is the fraction of the total population that is
exposed. AB is an attributive burden, or excess cases. P
is a baseline prevalence or incidence or mortality rates.
D is an average duration of the lung cancer until remis-
sion in years or YLL for the lung cancer mortality. S is
the severity weight of the lung cancer between 0
(healthy) and 1 (death) and it have been determined by
the Dutch Disability Weights Group [23]. The lowest RR
of the 95 % confidence interval was multiplied by the
lowest radon exposure estimate and severity weight to
calculate the lowest estimate of the lung cancer burden,
and the highest estimate was obtained in a similar
manner. Exposure level was 0.45–0.74 mSv/year, RRs
were derived from the BEIR VI report, severity was
0.43–0.54, and duration was 1.61 years. The number of
attributable lung cancer cases was 70–900. EBD for
radon was 1,000–14,000 DALYs. This was higher com-
pared to that of previous study (EnVIE), which was
1,300 DALYs [24]. It was because the 2013 Netherland
study included not just soil but building materials as
radon source, whereas EnVIE considered soil as the sole
radon source. And EnVIE study used PAF estimated
directly by the judgment of experts and disease burden
from burden of disease in the WHO database, which
were calculated with the standardized country-specific
data to optimize comparability across countries.
In Ontario, Canada in 2013, the study of burden of
lung cancer illness due to radon also calculated YLL and
population attributable risk percent, excess life-time risk
ratio, the number of lung cancer deaths due to radon
[25]. This study provided local level research and
evidence for 36 health units, varying in geographical and
population size. The method documented by Brand et
al. [26], based on the exposure-age-concentration model
from the BEIR-VI report, was implemented. The excess
risk ratio (ERR) of lung cancer mortality for age groups
with 5 year intervals was calculated with health unit-
specific radon exposure information and the percentage
of the population living in high-rise buildings. The un-
certainty in ERR was estimated with a Monte Carlo
simulation in order to capture exposure uncertainty and
inter-individual variability of the ERRs. In each health
unit, YLL, ELRR, and PAR % were calculated following
the equations.
YLL ¼ LE−LEE
ELRR ¼ LRE
LR−1
PAR % ¼ LRE−LRð Þ
LRE
 100
LR is lifetime risk and LE is life expectancy estimates
of lung cancer for each health unit. Estimates were
estimated separately for ever-smokers, never-smokers,
and combined (ever- and never-smokers, assuming that
92.5 % of lung cancers are in ever-smokers [27]). Data
were from the age-health unit-specific lung cancer, all-
cause mortality data, age-specific proportion of ever-
smokers in each health unit, and the age-specific RRs of
lung cancer and all cause mortality due to smoking. LRE
and LEE are estimates of lung cancer in exposed individ-
uals, which were calculated by the life-table multiplied
by the simulated ERRs. A population-weighted average
of the health unit estimates were used to calculate PAR
%, ELRR, and YLL estimates for the Ontario. The num-
ber of lung cancer deaths due to radon, in both never-
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and ever-smokers combined, were calculated as the
mean combined PAR % multiplied by the number of
lung cancer deaths in that health unit in 2007. In terms
of YLL for lung cancer patients, arithmetic mean for the
overall Ontario population was one-sixth of a life year
lost (0.164 years). Smoking population lost three times
more years than never-smokers. The arithmetic mean
PAR % estimates was 13.6 %, which means lung cancer
deaths within the Ontario are attributable to radon
(Table 3). Never-smokers had higher PAR % values
(21.9 %) than ever-smokers (12.3 %). At current levels in
Ontario, there was 16 % greater risk of lung cancer
compared to background levels (Table 3). In the never-
smoking population, the ELRR could be 1.304 (97.5 %
quintile), which was also higher than ever-smokers. In
addition, 36 health units across Ontario had a consider-
ably heterogeneous PAR % estimates.
The Ontario study was the first study estimating the
lung cancer burden attributable to radon by health unit
within a Canada. Likewise other disease burden study,
limitations of the study include the representativeness of
the exposure data, which was from fewer than 100
samples and radon levels vary widely for some health
units. The lung cancer burden estimates could be influ-
enced by the distribution of measured radon levels.
Conclusion
In summary, estimated global EBD attributable to residen-
tial radon was 1,503,000 (984,000 to 2,086,000) DALYs for
both sexes in GBD 1990. Estimates were 2,114,000
(273,000–4,660,000) and 1,979,000 (1,331,000–2,768,000)
DALYs for both sexes in GBD 2010 and 2013, respectively.
Stratified by sex, EBD estimates attributable to residential
radon were 1,514,000 (191,000–3,383,000) among
male and 600,000 (84,000–1,355,000) among female.
In United States, the age-standardized DALY and all
age DALY of lung cancer due to residential radon
was 183,200 (18,800 – 514,200) and 4,200,000 (430,000 –
11,720,000), respectively in 2010. In Netherlands, EBD for
radon was 1000–14,000 DALYs. Smoking population lost
three times more years than never-smokers (0.066 vs
0.198) in Canada, 2013. Although it has been reported
that the smoking status modifies the risk of lung cancer
associated with radon, EBD among never smokers has not
been explored yet. Furthermore there was no study
estimating EBD of residential radon among never smokers
in Korea. In addition, there were a few studies reflecting
the age of building, though residential radon exposure
level depends on the age of building. In conclusion,
further EBD study reflecting Korean disability weight and
the age of building is required to estimate EBD precisely.
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